Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06027554 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Mito-Frail Trial: Effects of MitoQ on Vasodilation, Mobility and Cognitive Performance in Frail Older Adults

Study acronym: Mito-Frail
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv9
  2. Primary completion date: Sep 1, 2025 to Mar 1, 2027
    • Study completion date: Jul 1, 2027 to Feb 1, 2028
    v8
  3. Start date: Sep 26, 2024 to Oct 7, 2024v7
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Feb 28, 2024 to Sep 26, 2024
    • Site details revised
    v6
  5. Trial status: Recruiting to Not Yet Recruitingv5 Show 4 more changesShow less
    • Primary completion date: Aug 31, 2026 to Sep 1, 2025
    • Study completion date: Mar 1, 2028 to Jul 1, 2027
    • Start date: Feb 6, 2024 to Feb 28, 2024
    • Site details revised
Show 3 earlier versionsHide 3 earlier versions
  1. Trial status: Not Yet Recruiting to Recruitingv4 Show 4 more changesShow less
    • Primary completion date: Sep 1, 2025 to Aug 31, 2026
    • Study completion date: Jul 1, 2027 to Mar 1, 2028
    • Start date changed from estimate of Feb 28, 2024 to Feb 6, 2024
    • Site details revised
  2. Start date: Sep 28, 2023 to Feb 28, 2024v3
  3. Primary endpoints revised (5)
    • Secondary endpoints revised (2)
    • Study description revised
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
UConn Health
38 trials monitored
See 2 trials at risk
The goal of this clinical trial is to test the effects of MitoQ supplementation in older adults and frail older adults with physical dysfunction and/or cognitive dysfunction. The main question\[s\] it aims to answer are: * To compare vascular function, oxidative stress levels, and physical and cognitive function among older adults and frail older adults with physical and cognitive dysfunction * To determine whether MitoQ supplementation has the potential to improve vascular function in central and cerebral vessels * To determine whether MitoQ supplementation can enhance physical and cognitive capabilities.
Trial Details
NCT Number NCT06027554
Lead Sponsor UConn Health
Collaborators: National Institute on Aging (NIA), University of Connecticut
Conditions
(from sponsor)		 Frailty, Mild Cognitive Impairment, Aging
Related terms Cognitive Dysfunction, Frailty
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov